Subscribe To Our Free Newsletter |
Sun Pharma gets US FDA nod for alopecia areata treatment drug LEQSELVI
Sun Pharmaceutical Industries said that it has received approval from the U.S. Food and Drug Administration (US FDA) for LEQSELVI (deuruxolitinib), an oral JAK Inhibitor for the treatment of severe alopecia areata.